AstraZeneca Wins U.S. Approval for First-line Use of Lung Cancer Drug AstraZeneca Wins U.S. Approval for First-line Use of Lung Cancer Drug

U.S. regulators have expanded use of AstraZeneca ' s lung cancer drug Tagrisso to include initial treatment of patients with a specific genetic mutation, the company said on Wednesday.FDA Approvals
Source: Medscape Hematology-Oncology Headlines - Category: Cancer & Oncology Tags: Hematology-Oncology News Alert Source Type: news